The United States is a global leader in medical innovation. Unfortunately, due to perverse incentives that exist in our current health care system to block lower-cost drugs from the marketplace, patients have difficulty accessing and affording those life-saving treatments. Biosimilars, which are nearly identical, lower-cost alternatives to complex biologic drugs, have the potential to increase competition and provide those benefits, but not unless the marketplace reflects that potential. The largest-selling prescription drug in history, Humira, is an excellent example of the opportunity and cost-savings that biosimilars represent. For 20 years, patients suffering from debilitating chr
Hence then, the article about affordable prescription drugs exist why can t more patients access them was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Affordable prescription drugs exist — why can’t more patients access them? )